Founded and supported by a team of world-class scientists, engineers, nephrology experts, and industry leaders, liberDi's mission is to free people on dialysis from the constraints of traditional treatments. Currently, 1 out of 10 people worldwide experience kidney disease or failure, with in-clinic hemodialysis being the most common treatment modality for 88% of patients. This means that individuals spend a significant amount of their time traveling to and undergoing treatment.

Even those who opt for home dialysis are still confined to their homes for hours each day. Recognizing this need for disruption, liberDi has developed a safe, patient-friendly, and portable solution. By providing a 360° platform for people with kidney disease and their caregivers, liberDi not only improves the quality of life for patients but also enables clinics to optimize their economic model and lower costs.

With its groundbreaking technology, liberDi is transforming the dialysis experience for everyone involved